T. Rowe Price Associates
STTK icon

T. Rowe Price Associates’s Shattuck Labs STTK Stock Holding History

T. Rowe Price Associates’s Portfolio STTK Stock Details STTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.5M Sell
1,782,788
-143,352
-7% -$680K ﹤0.01% 1184
2025
Q4 		$7.03M Buy
+1,926,140
New +$4.6M ﹤0.01% 1306
2025
Q2 		– Sell
-12,603
Closed -$12K – 3145
2025
Q1 		$12K Hold
12,603
– – ﹤0.01% 3024
2024
Q4 		$16K Sell
12,603
-19,300
-60% -$23.9K ﹤0.01% 3001
2024
Q3 		$112K Hold
31,903
– – ﹤0.01% 2797
2024
Q2 		$124K Buy
31,903
+12,603
+65% +$102K ﹤0.01% 2715
2024
Q1 		$173K Hold
19,300
– – ﹤0.01% 2663
2023
Q4 		$138K Hold
19,300
– – ﹤0.01% 2651
2023
Q3 		$30K Hold
19,300
– – ﹤0.01% 2831
2023
Q2 		$61K Hold
19,300
– – ﹤0.01% 2779
2023
Q1 		$57K Hold
19,300
– – ﹤0.01% 2772
2022
Q4 		$44K Hold
19,300
– – ﹤0.01% 2827
2022
Q3 		$53K Hold
19,300
– – ﹤0.01% 2830
2022
Q2 		$78K Sell
19,300
-2,316
-11% -$8.39K ﹤0.01% 2807
2022
Q1 		$92K Buy
21,616
+500
+2% +$2.84K ﹤0.01% 2864
2021
Q4 		$180K Buy
+21,116
New +$291K ﹤0.01% 2782

Other funds holding STTK

T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
CEI
Clark Estates Inc New York $416M AUM 6.04% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

T. Rowe Price Associates's STTK Position: Q1 2026 in Review

T. Rowe Price Associates reduced its Shattuck Labs (STTK) stake by 7.4% in Q1 2026, selling an estimated $680K and leaving 1,782,788 shares worth $11.5M. The position accounts for ﹤0.01% of the portfolio, ranked #1184.

T. Rowe Price Associates first reported a position in STTK in Q4 2021 and has held it in 16 quarters since. 84 funds tracked by Wall St. Rank hold STTK as of Q1 2026.

  • T. Rowe Price Associates held 1,782,788 shares of Shattuck Labs worth $11.5M as of Q1 2026.
  • T. Rowe Price Associates sold 143,352 Shattuck Labs shares in Q1 2026, an estimated $680K.
  • Shattuck Labs made up ﹤0.01% of T. Rowe Price Associates's portfolio in Q1 2026, its #1184 holding.
  • T. Rowe Price Associates first reported a position in Shattuck Labs in Q4 2021 and has held it in 16 quarters since.
  • 84 funds tracked by Wall St. Rank held Shattuck Labs as of Q1 2026.

Based on T. Rowe Price Associates's 13F filing for Q1 2026, filed 15 May 2026.